SCHEMBL22742131

SCHEMBL22742131

COc1ccc2cc(-c3cc(-c4cc5ccc(OC)cc5cc4OC)c(F)c(C)c3F)c(OC)cc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 3/20 0.42
▸ CYP2A6 P11509 2/20 0.42
▸ CYP11B1 P15538 4/20 0.41
▸ CYP11B2 P19099 4/20 0.41
▸ CYP1A1 P04798 4/20 0.39
▸ CYP1B1 Q16678 4/20 0.39
▸ GSTP1 P09211 1/20 0.39
▸ CYP2E1 P05181 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C8 P10632 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP4B1 P13584 1/20 0.39
▸ CYP2B6 P20813 1/20 0.39
▸ CYP3A5 P20815 1/20 0.39
▸ CYP2A7 P20853 1/20 0.39
▸ CYP3A7 P24462 1/20 0.39
▸ CYP2F1 P24903 1/20 0.39
▸ CYP2C18 P33260 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22743384 0.87 CYP1A1 (0.47) CYP1A2CYP2A6CYP11B1CYP11B2CYP1A1
SCHEMBL30092293 0.85 CYP1A2 (0.56) CYP1A2CYP2A6CYP11B1CYP11B2CYP1A1
SCHEMBL23371163 0.85 CYP1A2 (0.56) CYP1A2CYP2A6CYP11B1CYP11B2CYP1A1
SCHEMBL22741696 0.84 CYP1A2 (0.44) CYP1A2CYP2A6CYP11B1CYP11B2CYP1A1
SCHEMBL22741638 0.82 CYP1A2 (0.46) CYP1A2CYP2A6CYP11B1CYP11B2CYP1A1
SCHEMBL28327203 0.78 RAB9A (0.57) CYP1A2CYP2A6CYP11B1CYP11B2CYP1A1
SCHEMBL22741512 0.78 CYP1A2 (0.44) CYP1A2CYP2A6CYP11B1CYP11B2CYP1A1
SCHEMBL8558574 0.75 CA12 (0.65) CYP1A2CYP2A6CYP1A1CYP1B1GSTP1
SCHEMBL17912844 0.72 CYP1A2 (0.54) CYP1A2CYP2A6CYP11B1CYP11B2CYP1A1
SCHEMBL19750013 0.72 CYP2A6 (0.54) CYP1A2CYP2A6CYP3A4ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2020-12-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200377513-A1 NOVEL COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE PIEZO1, TMEM109, LEF1 CYP1A2 1206/4885CYP2A6 3474/4885CYP11B1 999/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback